The prostaglandin EP4 receptor is a master regulator of the expression of PGE2 receptors following inflammatory activation in human monocytic cells.

[1]  A. Manning-Boğ,et al.  Suppression of Inflammation with Conditional Deletion of the Prostaglandin E2 EP2 Receptor in Macrophages and Brain Microglia , 2013, The Journal of Neuroscience.

[2]  E. Taylor,et al.  Ca2+ signals evoked by histamine H1 receptors are attenuated by activation of prostaglandin EP2 and EP4 receptors in human aortic smooth muscle cells , 2013, British journal of pharmacology.

[3]  K. Iwatsubo,et al.  The Prostanoid EP4 Receptor and Its Signaling Pathway , 2013, Pharmacological Reviews.

[4]  D. Rotondo,et al.  Characterisation of the prostaglandin E2-ethanolamide suppression of tumour necrosis factor-α production in human monocytic cells. , 2013, Biochimica et biophysica acta.

[5]  H. Leaver,et al.  Therapeutic implications of disorders of cell death signalling: membranes, micro‐environment, and eicosanoid and docosanoid metabolism , 2012, British journal of pharmacology.

[6]  Baohong Zhang,et al.  miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs , 2012, Plant Molecular Biology.

[7]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[8]  J. Albina,et al.  Prostaglandin E2 Suppresses Lipopolysaccharide-Stimulated IFN-β Production1 , 2008, The Journal of Immunology.

[9]  I. Dougall,et al.  Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages , 2007, European Respiratory Journal.

[10]  A. Mancini,et al.  Early Growth Response Factor-1 Mediates Prostaglandin E2-dependent Transcriptional Suppression of Cytokine-induced Tumor Necrosis Factor-α Gene Expression in Human Macrophages and Rheumatoid Arthritis-affected Synovial Fibroblasts* , 2005, Journal of Biological Chemistry.

[11]  R. Young.  Discovery and Synthesis of a Potent, Selective and Orally Bioavailable EP4 Receptor Agonist , 2004 .

[12]  W. Walker,et al.  Prostaglandin E2 is a potent regulator of interleukin‐12‐ and interleukin‐18‐induced natural killer cell interferon‐γ synthesis , 2004, Immunology.

[13]  D. Ganea,et al.  Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. , 2003, Cellular immunology.

[14]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[15]  B. Koller,et al.  Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. , 2001, The Journal of clinical investigation.

[16]  Soken Tsuchiya,et al.  The Expression of Prostaglandin E Receptors EP2 and EP4 and Their Different Regulation by Lipopolysaccharide in C3H/HeN Peritoneal Macrophages1 , 2001, The Journal of Immunology.

[17]  Y. Sugimoto,et al.  Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. , 2000, Biochemical and biophysical research communications.

[18]  S. Al-Sedairy,et al.  A carbocyclic nucleoside analogue is a TNF-alpha inhibitor with immunosuppressive action: role of prostaglandin E2 and protein kinase C and comparison with pentoxifylline. , 1998, Cellular immunology.

[19]  P. Barnes,et al.  Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide‐induced tumour necrosis factor‐α generation , 1997, British journal of pharmacology.

[20]  K. Seibert,et al.  Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo , 1996, The Journal of experimental medicine.

[21]  R. L. Jones,et al.  Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues , 1993, British journal of pharmacology.

[22]  W. Dröge,et al.  Tumor necrosis factor-induced activation of peritoneal macrophages is regulated by prostaglandin E2 and cAMP. , 1988, Journal of immunology.

[23]  D. Remick,et al.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. , 1988, The Journal of biological chemistry.

[24]  J. Larrick,et al.  Regulation of macrophage tumor necrosis factor production by prostaglandin E2. , 1986, Biochemical and biophysical research communications.

[25]  I. Mlinarič-Raščan,et al.  Structural features of subtype-selective EP receptor modulators. , 2017, Drug discovery today.